Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (11): 698-698.
• Orginal Article • Previous Articles Next Articles
ZHANG Zhaohui, DU Hui, QU Bin*
Received:2019-01-09
Revised:2019-01-09
Online:2018-11-20
Published:2019-01-09
CLC Number:
ZHANG Zhaohui, DU Hui, QU Bin. One Case of Allergic Shock Induced by Atevacaine Epinephrine Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(11): 698-698.
| [1] 江永贤,李根,王涵,等. 王玉兰注射用戈那瑞林致过敏性休克1例[J].中国药物警戒,2018,15(8):504-505. [2] 赵世丹,鲁仲平. 影响个例药品不良反应报告评价的因素[J].中国药物警戒,2012,9(9):553-555. [3] 谢桂英,罗华强,裴切艳,等. 复方盐酸阿替卡因注射液致过敏性休克1例[J].实用医技杂志,2014,21(6): 695-696. [4] 夏丽华,许志红,王跃进. 盐酸阿替卡因肾上腺素注射液过敏1例[J].现代口腔医学杂志,2008,22(6):16. [5] 梅帅,朱辛奕,刘境华. 盐酸阿替卡因肾上腺素注射液过敏患者1例报告[J].中国民康医药2015:26(25):128. [6] 朱翔. 可疑焦亚硫酸钠过敏反应1例[J].中国乡村医学,2014,21(19):49. [7] 林瑶,薛晓娟,高亚,等. 阿替卡因肾上腺素注射液致过敏性休克1例[C]//中华医学会. 中华医学会临床药学分会2014年全国学术会议. 2014:39-40. [8] 李文梅. 阿替卡因肾上腺素注射液引起过敏反应1例[J]. 中国疗养医学,2012,21(2):170. [9] 余磊. 阿替卡因肾上腺素注射液引起过敏反应1例[J].海峡医学, 2012,24(1):256-257. [10] 王少坤,闫百灵,李薇,等. 复方盐酸阿替卡因注射液致急性喉头水肿窒息1例[J].中国老年学杂志,2012,32:(16):3548. [11] 景藏. 阿替卡因肾上腺素注射液浸润麻醉致面瘫1例[J]. 口腔医学,2005,25(6):350. [12] 郑利光,秦满牛,桂田. 阿替卡因肾上腺素注射液致局部组织坏死1例[J].中国药事,2008,22(9): 840. [13] 钟媛. 探讨优质护理服务应用在老年肺心病患者中对心理和生活质量的影响效果[J]. 世界最新医学信息文摘,2018,18(86):202. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
